Ottawa prepares for future pandemics with launch of life science strategy, CellCAN and CCRM launch a new cell and gene therapy institute to tackle gaps in training, a new fund dedicated to developing transit solutions for rural and remote communities, and more.
Organization: Northleaf |Capital Partners
Ottawa and partners commit $60 million to natural resources and environmental genomics projects, applied research funding at Canadian colleges gets a boost, and more.
The federal government is backing five large venture capital (VC) fund of funds (FoF) to boost the much-needed late-stage capital available to Canadian tech firms.
Northleaf |Capital Partners‘s Northleaf Venture Catalyst Fund is an anchor investor in Vancouver-based Version One Ventures II. The $10-million investment will be used by Version One for seed and series A financing of Internet, SaaS (software as a service) and mobile entrepreneurs. Northleaf is an offshoot of the TD Bank Financial Group and is backed…